Trump signs order to accelerate Ibogaine research for veterans with PTSD

President Donald Trump signed an executive order on April 18, 2026, directing federal agencies to accelerate research into ibogaine as a potential treatment for veterans suffering from post-traumatic stress disorder (PTSD) and other conditions, citing the need to expand access to emerging therapies.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.